Clinical Trials Directory

Trials / Completed

CompletedNCT01759992

Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People

Determination of the Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People With Functional Impairment: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
University of Valencia · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The global loss of muscle mass and strength associated with aging is a cause of functional impairment and disability, particularly in the older elderly (\>80 years). Respiratory function can be severely compromised if there is a decrease of respiratory (RM) strength complicated by the presence of comorbidities and physical immobility. In this context, the need for supportive services involves the need for long-term care and consequently the institutionalization. Previous studies have shown that the increase of RM strength has positive healthy effects, such as the increase in functional capacity, the decrease in RM fatigue, the decrease of dyspnoea and the improvement of quality of life, both in healthy people and patients. Therefore, specific RM training may be regarded as a beneficial alternative to improve RM function, and thus prevent physical and clinical deterioration in this frail population. Study hypothesis: The inspiratory muscle training (IMT) would improve respiratory muscle strength and endurance, exercise capacity and quality of life in an elderly population, who are unable to engage in general exercise conditioning.

Conditions

Interventions

TypeNameDescription
DEVICEThreshold® Inspiratory Muscle Trainer (treatment).Interval-based program consisting of seven cycles of 2-minutes work and 1-minute rest. The sessions will take place 3 times per week over a eight-week period for a total of 24 sessions. All participants were familiarized with the breathing exercises over a two-week familiarization period at the beginning of the protocol. The load will be adjusted at ≥ 50% of baseline MIP.

Timeline

Start date
2013-01-01
Primary completion
2013-07-01
Completion
2013-12-01
First posted
2013-01-03
Last updated
2014-03-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01759992. Inclusion in this directory is not an endorsement.